Integ, Inc.

Restore Medical, Inc.

Abbott Molecular Inc.

Medtronic Xomed, Inc.

Nevro Corporation

Lifescan Corporation

Enteromedics Inc.

Medtronix Xomed, Inc.

Brian J Erickson

Mark B Knudson

Michael E Hilgers

John P Sopp

Timothy R Conrad

Anja Metzger

J Edward Shapland

Tracy A Hendrickson

Frank A Solomon

Shihai X Huang

Susan L Critzer

Scott T Latterell

Paul D Brinda

John A Salituro

Wai-Bing X Mak

Michael J Shoup

Thomas B Hoegh

Klara Abravaya

Ning Tang

Andre B Walker

Anthony V Caparso

Konstantinos Alataris

Joel R Racchini

Zi-Ping Fang

Philip J Stout

Arthur J Foster

John J Allen

John M Allen

Kurt D Krueger

John R Frigstad

Larry A Walter

Dominik Duelli

Hong X Su

Chad Dunn

Amanda Goldston

Michael D Bierk

Hong Su

Anja K Metzger

The disclosure is directed to methods, kits, and compositions, for amplifying and detecting a human hepatitis B virus (HBV) in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.

Assay for detecting hepatitis B virus (HBV)

The present invention relates to primers, probes, primer sets, primer and probe sets, methods and kits for detecting human papillomaviruses, human beta globin sequences and human papillomaviruses and human beta globin sequences in a test sample.

Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples

The present invention provides novel and non-obvious improvements to dried blood spot testing for HIV-1 viral load useful for diagnosis and monitoring treatment progression.

Automated HIV-1 viral load testing procedure for dried spots

A method of designing a primer for detecting a single nucleotide polymorphism (SNP), a method of detecting an SNP, a method of distinguishing SNPs, primers, detectable oligonucleotides, and kits.

Method of designing primers, method of detecting single nucleotide polymorphisms (SNPs), method of distinguishing SNPs, and related primers, detectable oligonucleotides, and kits

Multi-frequency neural treatments and associated systems and methods are disclosed. A method in accordance with a particular embodiment includes at least reducing patient pain by applying a first electrical signal to a first target location of the patient's spinal cord region at a frequency in a first frequency range of up to about 1,500 Hz, and applying a second electrical signal to a second target location of the patient's spinal cord region at a frequency in a second frequency range of from about 2,500 Hz to about 100,000 Hz.

Multi-frequency neural treatments and associated systems and methods

A pharyngeal airway having a pharyngeal wall of a patient at least partially surrounding and defining the airway is treated by selecting an implant dimensioned so as to be implanted at or beneath a mucosal layer of the pharyngeal wall and extending transverse to said wall. The implant has mechanical characteristics for the implant, at least in combination with a fibrotic tissue response induced by the implant, to stiffen said pharyngeal wall to resist radial collapse. The implant is implanted into the pharyngeal wall transverse to a longitudinal axis of the airway.

Stiffening pharyngeal wall treatment

Treatment for sleep apnea or snoring

An apparatus for applying a signal to a nerve for the treatment of a disorder includes a main electrode body of biocompatible dielectric material and having a concave upper surface and an opposite lower surface. The concave upper surface curves about an axis and has a curvature sized to receive a nerve within the concave surface with an axis of the nerve substantially parallel to an axis of the concave surface. An electrode contact of electrically conductive material is secured to the main electrode body and has an electrode contact surface exposed on the concave surface. The concave surface terminates at opposite first and second upper ends. The electrode contact has a first end near the first end of the concave surface. A secondary electrode body of biocompatible dielectric material is attached to the first upper end of the concave surface. An electrode lead has an electrical conductor surrounded by a biocompatible insulative coating with both the conductor and the coating flexible relative to a longitudinal axis of the lead. A first end of the lead is secured to the secondary electrode body and with a first end of said conductor electrically connected to said first end of said electrode contact.

Custom sized neural electrodes

An airway condition of a patient's is treated by selecting an implant sized to be implanted within a tongue of the patient. The implant has a tissue-engaging member sized to be implanted within the tongue near a base of the tongue to oppose relative movement between the tissue-engaging member and surrounding tissue of the tongue. The implant further has an elongated tether member with a first end secured to the tissue-engaging member. The implant is placed within the tongue with the tissue-engaging member implanted within tissue of the tongue near the base and with the tether member extending from the first end to a second end near a jaw bone of the patient. The second end of the tether is secured to the jaw bone.

Tongue implant

An airway condition of a patient is treated by selecting an implant sized to be implanted within a soft palate of the patient. The implant has a tissue-engaging member sized to be implanted within the soft palate near a trailing end of the soft palate to oppose relative movement between the tissue-engaging member and surrounding tissue of the soft palate. The implant further has an elongated tether member with a first end secured to the tissue-engaging member. The implant is placed within the soft palate with the tissue-engaging member implanted within tissue of the soft palate near the trailing end and with the tether member extending from the first end to a second end near a hard palate of the patient. The second end of the tether is secured to the hard palate.

Soft palate implant

Methods and apparatuses are disclosed for treating a condition of a patient's airway. The condition is attributed at least in part to a spacing of tissue from opposing surfaces in the airway. In various embodiments, the base of the tongue including geometry and position of the tongue is altered.

Airway implant

Growing community of inventors

Woodbury, MN, United States of America

Brian J Erickson